USPTO serial 79356625
IMMUNE BEE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with IMMUNE BEE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations; medical and therapeutic preparations; pharmaceutical and therapeutic preparations for healthcare; nutraceuticals; cosmeceuticals for medical and/or therapeutic purposes; medicated health foods and drinks; medicated health foods and drinks containing propolis and/or propolis extracts; dietetic preparations and substances adapted for medical use; dietetic foods and beverages adapted for medical purposes; dietary and nutritional supplements; dietary and nutritional supplements containing bee products, including one or more of honey, royal jelly, bee venom, beeswax, propolis; propolis dietary and nutritional supplements including in capsule, soft gel, gummy, tablet, lozenge and/or oral spray form; propolis for pharmaceutical purposes including in capsule, soft gel, gummy, tablet and/or oral spray form; propolis for medical purposes including in capsule, soft gel, gummy, tablet, lozenge and/or oral spray form; dietary and nutritional supplements containing olive products including one or more of olive fruit, olive leaf, olive leaf extract, olive oil; nutritional and dietary supplements for stress relief including those containing one or more of ginseng, saint john's wort, ashwagandha, turmeric, lavender, kava, curcumin; vitamin formulations; minerals, namely, food and dietary supplements; mineral formulations for medical and therapeutic purposes; foods, supplements and beverages for babies and infants; dietetic foods, supplements and beverages for patients, adapted for medical use; therapeutic drinks, including teas, tonics and infusions; tonics for therapeutic, medicinal and dental purposes; probiotics supplements; probiotic preparations for medical use; medicated confectionery; dietary and nutritional supplements in capsule, soft gel, gummy, tablet, lozenge, powder, chew, milk chew, gummy, lolly and/or oral spray form; antimicrobial and antiseptic lozenges, pastilles, lollipops, soft gels, oral sprays, tinctures, tablets and/or capsules; elixirs; lotions, creams, balms, serums, and oils for medical and therapeutic purposes; dermatological preparations, creams and lotions; preparations for the treatment of skin irritations, cuts, abrasions, dermatitis, bruising, sun burn, psoriasis and eczema; topical dermatological preparations that treat insect bites and stings; medicated skin care products; cold sore treatment preparations; nail fungus treatment preparations; nail sanitising preparations; wound-care products in this class, namely, topical preparations, wound dressings, medical dressings, surgical dressings, plasters, lotions, ointments, creams, sprays and elixirs; antiseptic medical and surgical gauzes; plasters; cold relief preparations; headache relief preparations; soporifics including those containing one or more of magnesium, melatonin, valerian, passionflower, chamomile; medicated creams, balms, lotions, preparations, gels, tinctures and ointments for oral or topical use; medicated creams, balms, lotions, preparations, gels, elixirs, teas, infusions, tinctures and ointments for oral or topical use made from or containing bee products including one or more of honey, royal jelly, bee venom, beeswax, propolis; medicated creams, balms, lotions, preparations, gels, elixirs, teas, infusions, tinctures and ointments for oral or topical use made from or containing olive products including one or more of olive fruit, olive leaf, olive leaf extract, olive oil; dentifrices for medical or therapeutic purposes; mouthwashes for medical or therapeutic purposes; medicated throat sprays; medicated toothpastes; propolis toothpaste for medical or therapeutic purposes; therapeutic, topical pharmaceutical preparations, dietary and medical preparations containing one or more of honey, royal jelly, bee venom, beeswax, propolis, selenium, bilberry, kiwifruit, berries, colostrum, calcium, milk, vitamin c, l-lysine, omega 3, evening primrose oil, garlic, lemon, echinacea, zinc, tea tree oil, olive fruit, olive oil, olive leaf, olive leaf extract, deer velvet; eye drops; medicated lip balms, tinctures and ointments; wipes impregnated with antiseptic or medicated wipes; sanitary products and preparations for medical purposes; disinfectants; vermin destroying preparations; fungicides; herbicides; insect repellents; veterinary preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 22, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 6, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 6, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 21, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 1, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 1, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 5, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 5, 2024 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 5, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 16, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 6, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |